Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4513871, 8 pages
http://dx.doi.org/10.1155/2016/4513871
Research Article

Gmelina arborea Roxb. (Family: Verbenaceae) Extract Upregulates the β-Cell Regeneration in STZ Induced Diabetic Rats

1Department of Biochemistry, Faculty of Medicine, University of Ruhuna, 80000 Galle, Sri Lanka
2Department of Pathology, Faculty of Medicine, University of Ruhuna, 80000 Galle, Sri Lanka

Received 19 August 2015; Revised 12 November 2015; Accepted 1 December 2015

Academic Editor: Janet H. Southerland

Copyright © 2016 Anoja Priyadarshani Attanayake et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, supplement 1, pp. S14–S80, 2014. View at Publisher · View at Google Scholar
  2. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Veiseh, B. C. Tang, K. A. Whitehead, D. G. Anderson, and R. Langer, “Managing diabetes with nanomedicine: challenges and opportunities,” Nature Reviews Drug Discovery, vol. 14, pp. 45–57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bastaki, “Diabetes mellitus and its treatment,” International Journal of Diabetes and Metabolism, vol. 13, no. 3, pp. 111–134, 2005. View at Google Scholar · View at Scopus
  5. R. R. Chattopadhyay, “A comparative evaluation of some blood sugar lowering agents of plant origin,” Journal of Ethnopharmacology, vol. 67, no. 3, pp. 367–372, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. A. Jayaweera, Medicinal Plants (Indigenous and Exotic) Used in Ceylon, National Science Foundation in Sri Lanka, Colombo, Sri Lanka, 2nd edition, 1982.
  7. E. R. H. S. S. Ediriweera and W. D. Ratnasooriya, “A review on herbs used in treatment of diabetes mellitus by Sri Lankan Ayurvedic and traditional physicians,” AYU, vol. 30, pp. 373–391, 2009. View at Google Scholar
  8. A. P. Attanayake, K. A. P. W. Jayatilaka, C. Pathirana, and L. K. B. Mudduwa, “Antioxidant activity of Gmelina arborea Roxb. (Verbenaceae) bark extract: in vivo and in vitro study,” Journal of Medical Nutrition and Nutraceuticals, vol. 4, no. 1, pp. 32–38, 2015. View at Publisher · View at Google Scholar
  9. A. P. Attanayake, K. A. P. W. Jayatilaka, C. Pathirana, and L. K. B. Mudduwa, “Sub-chronic toxicological investigation of Gmelina arborea (Verbenaceae) in healthy Wistar rats,” International Journal of Pharmaceutical Sciences and Research, vol. 4, no. 12, pp. 4549–4554, 2013. View at Google Scholar
  10. A. P. Attanayake, K. A. P. W. Jayatilaka, C. Pathirana, and L. K. Mudduwa, “Acute hypoglycemic and antihyperglycemic effects of ten Sri Lankan medicinal plant extracts in healthy and streptozotocin induced diabetic rats,” International Journal of Diabetes in Developing Countries, vol. 35, no. 3, pp. 177–183, 2015. View at Publisher · View at Google Scholar
  11. J. Sokolovska, S. Isajevs, O. Sugoka et al., “Comparison of the effects of glibenclamide on metabolic parameters, GLUT1 expression, and liver injury in rats with severe and mild streptozotocin-induced diabetes mellitus,” Medicina, vol. 48, no. 10, pp. 532–543, 2012. View at Google Scholar · View at Scopus
  12. C. F. B. Vasconcelos, H. M. L. Maranhão, T. M. Batista et al., “Hypoglycaemic activity and molecular mechanisms of Caesalpinia ferrea Martius bark extract on streptozotocin-induced diabetes in Wistar rats,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1533–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Trinder, “Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen,” Journal of Clinical Pathology, vol. 22, no. 2, pp. 158–161, 1969. View at Publisher · View at Google Scholar · View at Scopus
  14. R. D. Purves, “Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC),” Journal of Pharmacokinetics and Biopharmaceutics, vol. 20, no. 3, pp. 211–226, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. E. C. Abraham, T. A. Huff, N. D. Cope et al., “Determination of the glycosylated haemoglobin (HbA1C) with a new micro column procedure: suitability of the technique for assessing the clinical management of diabetes mellitus,” Diabetes, vol. 27, no. 9, pp. 931–937, 1978. View at Google Scholar
  16. R. N. Johnson, P. A. Metcalf, and J. R. Baker, “Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control,” Clinica Chimica Acta, vol. 127, no. 1, pp. 87–95, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Andersen, B. Dinesen, P. N. Jorgensen, F. Poulsen, and M. E. Roder, “Enzyme immunoassay for intact human insulin in serum or plasma,” Clinical Chemistry, vol. 39, no. 4, pp. 578–582, 1993. View at Google Scholar · View at Scopus
  18. J. P. Ashby and B. M. Frier, “Circulating C-peptide: measurement and clinical application,” Annals of Clinical Biochemistry, vol. 18, no. 3, pp. 125–130, 1981. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Roeschlau, E. Bernt, and W. Gruber, “Enzymatic determination of total cholesterol in serum,” Zeitschrift fur klinische Chemie und klinische Biochemie, vol. 12, no. 5, article 226, 1974. View at Google Scholar · View at Scopus
  20. G. Assmann, H. Schriewer, G. Schmitz, and E. O. Hagele, “Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2,” Clinical Chemistry, vol. 29, no. 12, pp. 2026–2030, 1983. View at Google Scholar · View at Scopus
  21. A. W. Wahlefeld, “Triglycerides: determination after enzymatic hydrolysis,” in Method of Enzymatic Analysis, H. K. Bergmeyer, Ed., pp. 1825–1831, Academic Press, New York, NY, USA, 1974. View at Google Scholar
  22. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  23. Q. G. Li, R. Sun, and F. Z. Gao, “Effect of Shen Di Jiang Tang granules on diabetic rats,” China Journal of Chinese Materia Medica, vol. 26, pp. 488–490, 2001. View at Google Scholar
  24. R. R. MacGregor, S. J. Williams, P. Y. Tong, K. Kover, W. V. Moore, and L. Stehno-Bittel, “Small rat islets are superior to large islets in in vitro function and in transplantation outcomes,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 5, pp. E771–E779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Elayat, M. M. El-Naggar, and M. Tahir, “An immunocytochemical and morphometric study of the rat pancreatic islets,” Journal of Anatomy, vol. 186, no. 3, pp. 629–637, 1995. View at Google Scholar · View at Scopus
  26. A. J. F. King, “The use of animal models in diabetes research,” British Journal of Pharmacology, vol. 166, no. 3, pp. 877–894, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Nukatsuka, Y. Yoshimura, M. Nishida, and J. Kawada, “Importance of the concentration of ATP in rat pancreatic beta cells in the mechanism of streptozotocin-induced cytotoxicity,” Journal of Endocrinology, vol. 127, no. 1, pp. 161–165, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. D. C. Almonte-Flores, N. Paniagua-Castro, G. Escalona-Cardoso, and M. Rosales-Castro, “Pharmacological and genotoxic properties of polyphenolic extracts of Cedrela odorata L. and Juglans regia L. barks in rodents,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 187346, 8 pages, 2015. View at Publisher · View at Google Scholar
  29. C. O. Eleazu, K. C. Eleazu, and M. A. Iroaganachi, “Effect of cocoyam (Colocasia esculenta), unripe plantain (Musa paradisiaca) or their combination on glycated hemoglobin, lipogenic enzymes, and lipid metabolism of streptozotocin-induced diabetic rats,” Pharmaceutical Biology, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  30. J. E. Jackson and R. Bressler, “Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1,” Drugs, vol. 22, no. 3, pp. 211–245, 1981. View at Publisher · View at Google Scholar · View at Scopus
  31. B. I. Patel and P. D. Sachdeva, “Anti-diabetic activity of linaria amosissima (wall) Janch in streptozotocin induced diabetic rats,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 7, pp. 166–171, 2014. View at Google Scholar
  32. S. S. Fatima, M. D. Rajasekhar, K. V. Kumar, M. T. S. Kumar, K. R. Babu, and C. A. Rao, “Antidiabetic and antihyperlipidemic activity of ethyl acetate: isopropanol (1:1) fraction of Vernonia anthelmintica seeds in Streptozotocin induced diabetic rats,” Food and Chemical Toxicology, vol. 48, no. 2, pp. 495–501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. I. Levy, “High density lipoproteins, 1978—an overview,” Lipids, vol. 13, no. 12, pp. 911–913, 1978. View at Google Scholar
  34. R. Rajalingam, N. Srinivasan, and P. Govindarajulu, “Effects of alloxan induced diabetes on lipid profiles in renal cortex and medulla of mature albino rats,” Indian Journal of Experimental Biology, vol. 31, no. 6, pp. 577–579, 1993. View at Google Scholar · View at Scopus
  35. K. N. Bopanna, J. Kannan, S. Gadgil, R. Balaraman, and S. P. Rathod, “Antidiabetic and antihyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits,” Indian Journal of Pharmacology, vol. 29, no. 3, pp. 162–167, 1997. View at Google Scholar · View at Scopus
  36. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Banerjee, M. Kanitkar, and R. R. Bhonde, “Approaches towards endogenous pancreatic regeneration,” The Review of Diabetic Studies, vol. 2, no. 3, pp. 165–165, 2005. View at Publisher · View at Google Scholar
  39. I. E. Juárez-Rojop, J. C. Díaz-Zagoya, J. L. Ble-Castillo et al., “Hypoglycemic effect of Carica papaya leaves in streptozotocin-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 12, article 236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. N. Nagappa, P. A. Thakurdesai, N. Venkat-Rao, and J. Singh, “Antidiabetic activity of Terminalia catappa Linn fruits,” Journal of Ethnopharmacology, vol. 88, no. 1, pp. 45–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Babujanarthanam, P. Kavitha, and M. R. Pandian, “Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes,” Fundamental and Clinical Pharmacology, vol. 24, no. 3, pp. 357–364, 2010. View at Publisher · View at Google Scholar · View at Scopus